Low-dose metronomic eribulin in metastatic breast cancer: Is this real metronomic therapy?

被引：0
|
作者：
Altundag, Kadri [1 ]
机构：
[1] MKA Breast Canc Clin, Ankara, Turkey
来源：
JOURNAL OF BUON | 2021年 / 26卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1174 / 1174
页数：1
相关论文
共 50 条
  • [21] Metastatic breast cancer patients treated with low-dose metronomic chemotherapy with cyclophosphamide and celecoxib: clinical outcomes and biomarkers of response
    Herman Andres Perroud
    Carlos Maria Alasino
    Maria Jose Rico
    Leandro Ernesto Mainetti
    Francisco Queralt
    Stella Maris Pezzotto
    Viviana Rosa Rozados
    O. Graciela Scharovsky
    Cancer Chemotherapy and Pharmacology, 2016, 77 : 365 - 374
  • [22] Low-Dose Metronomic Oral Administration of Vinorelbine in the First-line Treatment of Elderly Patients With Metastatic Breast Cancer
    Addeo, Raffaele
    Sgambato, Alessandro
    Cennamo, Gregorio
    Montella, Liliana
    Faiola, Vincenzo
    Abbruzzese, Alberto
    Capasso, Elena
    Leo, Luigi
    Botti, Gerardo
    Caraglia, Michele
    Del Prete, Salvatore
    CLINICAL BREAST CANCER, 2010, 10 (04) : 301 - 306
  • [23] Low-dose metronomic chemotherapy: Myth or truth?
    Baruchel, Sylvain
    Stempak, Diana
    ONKOLOGIE, 2006, 29 (07): : 305 - 307
  • [24] Metronomic oral chemotherapy in metastatic breast cancer
    Mateen, A.
    Adil, A.
    Maken, R. N.
    ANNALS OF ONCOLOGY, 2015, 26 : 31 - 31
  • [25] Metronomic cyclophosphamide and methotrexate for breast cancer: Enhanced efficacy by adding dalteparin and low-dose prednisone?
    Buckman, Robert
    BREAST, 2011, 20 (05): : 483 - 484
  • [26] The use of low-dose metronomic chemotherapy in dogsinsight into a modern cancer field
    Gaspar, T. B.
    Henriques, J.
    Marconato, L.
    Queiroga, F. L.
    VETERINARY AND COMPARATIVE ONCOLOGY, 2018, 16 (01) : 2 - 11
  • [27] Low-dose "metronomic chemotherapy" with oral cyclophosphamide and methotrexate in metastatic breast cancer: a case report of extraordinarily prolonged clinical benefit
    Masci, G.
    Losurdo, A.
    Gandini, C.
    Garassino, I.
    di Tommaso, L.
    Torrisi, R.
    Zuradelli, M.
    Santoro, A.
    ECANCERMEDICALSCIENCE, 2012, 6
  • [28] Metronomic low-dose oral cyclophosphamide and methotrexate plus or minus thalidomide in metastatic breast cancer:: antitumor activity and biological effects
    Colleoni, M
    Orlando, L
    Sanna, G
    Rocca, A
    Maisonneuve, P
    Peruzzotti, G
    Ghisini, R
    Sandri, MT
    Zorzino, L
    Nolè, F
    Viale, G
    Goldhirsch, A
    ANNALS OF ONCOLOGY, 2006, 17 (02) : 232 - 238
  • [29] SAFETY AND EFFICACY OF VINORELBINE PLUS LOW-DOSE METRONOMIC CYCLOPHOSPHAMIDE IN PATIENTS WITH METASTATIC BREAST CANCER PREVIOUSLY TREATED WITH ANTHRACYCLINES AND TAXANES
    Kudo, S.
    Makino, T.
    Hasunuma, A.
    Ahiko, Y.
    ANNALS OF ONCOLOGY, 2014, 25
  • [30] Oral pemetrexed facilitates low-dose metronomic therapy and enhances antitumor efficacy in lung cancer
    Mahmud, Foyez
    Jeon, Ok-Cheol
    Alam, Farzana
    Maharjan, Ruby
    Choi, Jeong Uk
    Park, Jooho
    Lee, Sojung
    Park, Jin Woo
    Lee, Dong Soo
    Byun, Youngro
    JOURNAL OF CONTROLLED RELEASE, 2018, 284 : 160 - 170
12345